Table 3.

Multivariate analyses of disease-free survival (DFS) in the 68 patients included in the adjuvant series.

DFS	HR	CI95%(HR)	p-value
$\frac{\mathbf{Hazard}\left(\mathrm{Hormone}\mathrm{receptor}\mathrm{positive}\right)}{\mathbf{Hazard}\left(\mathrm{Hormone}\mathrm{receptor}\mathrm{negative}\right)}$	0.19	0.05–0.70	0.012
$\frac{\mathbf{Hazard}(\mathbf{TX}-\mathbf{T}1)}{\mathbf{Hazard}(\mathbf{T}2-\mathbf{T}4)}$	0.20	0.05–0.73	0.015
$\frac{\mathbf{Hazard}(\mathbf{NX}-\mathbf{N}0)}{\mathbf{Hazard}(\mathbf{N}1-\mathbf{N}3)}$	1.19	0.36–3.94	0.777
$\frac{\mathbf{Hazard}(\mathbf{HER}2\ge 2200)}{\mathbf{Hazard}(\mathbf{HER}2<2200)}$	0.24	0.06–0.96	0.044